mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant von Garcia-Beltran, Wilfredo F., St. Denis, Kerri J., Hoelzemer, Angelique, Lam, Evan C., Nitido, Adam D., Sheehan, Maegan L., Berrios, Cristhian, Ofoman, Onosereme, Chang, Christina C., Hauser, Blake M., Feldman, Jared, Roederer, Alex L., Gregory, David J., Poznansky, Mark C., Schmidt, Aaron G., Iafrate, A. John, Naranbhai, Vivek, Balazs, Alejandro B.

Volltext

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals von Naranbhai, Vivek, Nathan, Anusha, Kaseke, Clarety, Berrios, Cristhian, Khatri, Ashok, Choi, Shawn, Getz, Matthew A., Tano-Menka, Rhoda, Ofoman, Onosereme, Gayton, Alton, Senjobe, Fernando, Zhao, Zezhou, St Denis, Kerri J., Lam, Evan C., Carrington, Mary, Garcia-Beltran, Wilfredo F., Balazs, Alejandro B., Walker, Bruce D., Iafrate, A. John, Gaiha, Gaurav D.

Volltext

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study von Naranbhai, Vivek, Pernat, Claire A, Gavralidis, Alexander, St Denis, Kerri J, Lam, Evan C, Spring, Laura M, Isakoff, Steven J, Farmer, Jocelyn R, Zubiri, Leyre, Hobbs, Gabriela S, How, Joan, Brunner, Andrew M, Fathi, Amir T, Peterson, Jennifer L, Sakhi, Mustafa, Hambelton, Grace, Denault, Elyssa N, Mortensen, Lindsey J, Perriello, Lailoo A, Bruno, Marissa N, Bertaux, Brittany Y, Lawless, Aleigha R, Jackson, Monica A, Niehoff, Elizabeth, Barabell, Caroline, Nambu, Christian N, Nakajima, Erika, Reinicke, Trenton, Bowes, Cynthia, Berrios-Mairena, Cristhian J, Ofoman, Onosereme, Kirkpatrick, Grace E, Thierauf, Julia C, Reynolds, Kerry, Willers, Henning, Beltran, Wilfredo-Garcia, Dighe, Anand S, Saff, Rebecca, Blumenthal, Kimberly, Sullivan, Ryan J, Chen, Yi-Bin, Kim, Arthur, Bardia, Aditya, Balazs, Alejandro B, Iafrate, A John, Gainor, Justin F

Volltext

Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer von Naranbhai, Vivek, St. Denis, Kerri J., Lam, Evan C., Ofoman, Onosereme, Garcia-Beltran, Wilfredo F., Mairena, Cristhian B., Bhan, Atul K., Gainor, Justin F., Balazs, Alejandro B., Iafrate, A. John, Sullivan, Ryan J., Bardia, Aditya, Spring, Laura M., Isakoff, Steven J., Farmer, Jocelyn R., Zubiri, Leyre, Hobbs, Gabriella S., How, Joan, Brunner, Andrew M., Fathi, Amir T., Pernat, Clarie A., Gavralidis, A., Peterson, Jennifer L., Sakhi, Mustafa, Hambelton, Grace, Denault, Elyssa N., Mortensen, Lindsey J., Periello, Lailoo A., Bruno, Marissa N., Bruno, M.N., Betraux, Brittany Y., Lawless, Alyssa R., Jackson, Melissa A., Niehoff, Elizabeth, Barabell, Claire, Nambu, Christain N., Nakajima, Erika, Reinecke, Thomas, Bowes, Cyndi, Kirkpatrick, Grace E., Thierauf, Julia C., Reynolds, Kerri, Willers, Henning, Dighe, Anand S., Saff, Rebecca, Blumenthal, Kimberley

Volltext

T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals von Naranbhai, Vivek, Nathan, Anusha, Kaseke, Clarety, Berrios, Cristhian, Khatri, Ashok, Choi, Shawn, Getz, Matthew A., Tano-Menka, Rhoda, Ofoman, Onosereme, Gayton, Alton, Senjobe, Fernando, Zhao, Zezhou, St Denis, Kerri J., Lam, Evan C., Carrington, Mary, Garcia-Beltran, Wilfredo F., Balazs, Alejandro B., Walker, Bruce D., Iafrate, A. John, Gaiha, Gaurav D.

Volltext

Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency von Barmettler, Sara, DiGiacomo, Daniel V., Yang, Nancy J., Lam, Tiffany, Naranbhai, Vivek, Dighe, Anand S., Burke, Kristin E., Blumenthal, Kimberly G., Ling, Morris, Hesterberg, Paul E., Saff, Rebecca R., MacLean, James, Ofoman, Onosereme, Berrios, Cristhian, St Denis, Kerri J., Lam, Evan C., Gregory, David, Iafrate, Anthony John, Poznansky, Mark, Lee, Hang, Balazs, Alejandro, Pillai, Shiv, Farmer, Jocelyn R.

Volltext